MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could revolutionize Post-Surgery cancer care
Disease control Recruiting nowThis large trial is testing if a simple blood test can better identify which patients need extra treatment after surgery for aggressive urinary tract cancers. The test looks for tiny traces of cancer DNA in the blood. Patients are then assigned to receive either one or two immuno…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Bladder cancer breakthrough? trial tests cutting treatment time by 75%
Disease control Recruiting nowThis large Phase 3 trial is testing whether a much shorter, more intense course of radiation (5 sessions) works as well as the standard longer course (20 sessions) for patients with muscle-invasive bladder cancer. All participants will also receive standard chemotherapy. The main…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New Bladder-Saving combo could spare cancer patients major surgery
Disease control Recruiting nowThis study is testing whether a combination of radiation therapy and an immunotherapy drug (pembrolizumab) can help patients with muscle-invasive bladder cancer avoid having their bladder surgically removed. It is for patients whose tumors have shrunk significantly after initial …
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug duo offers hope to bladder cancer patients: keep your bladder, skip major surgery
Disease control Recruiting nowThis study is testing whether a combination of two drugs, enfortumab vedotin and pembrolizumab, can effectively treat muscle-invasive bladder cancer. The goal is to see if the drugs can shrink the tumor enough so that some patients can avoid having their bladder surgically remove…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Matthew Galsky • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Blood and urine test could help surgeons spot hidden bladder cancer
Diagnosis Recruiting nowThis study is testing whether a new combination of tests can better identify invasive bladder cancer before a patient has surgery to remove their bladder. Researchers will check if a special blood test and urine test, used alongside a standard scope exam, can accurately predict w…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC